SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874015-17-000054
Filing Date
2017-08-09
Accepted
2017-08-08 17:50:14
Documents
55
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 IONIS PHARMACEUTICALS INC 10-Q 6-30-2017 form10q.htm 10-Q 1255112
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 7712
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 7336
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 5772
  Complete submission text file 0000874015-17-000054.txt   6813221

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ions-20170630.xml EX-101.INS 1459614
6 XBRL TAXONOMY EXTENSION SCHEMA ions-20170630.xsd EX-101.SCH 52904
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ions-20170630_cal.xml EX-101.CAL 66643
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ions-20170630_def.xml EX-101.DEF 315731
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20170630_lab.xml EX-101.LAB 751844
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20170630_pre.xml EX-101.PRE 432878
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 171015883
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1